The store will not work correctly when cookies are disabled.
5-methoxy-2-(2-methylphenyl)-2,3-dihydroquinazolin-4(1H)-one
ID: ALA5200761
PubChem CID: 164880768
Max Phase: Preclinical
Molecular Formula: C16H16N2O2
Molecular Weight: 268.32
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: COc1cccc2c1C(=O)NC(c1ccccc1C)N2
Standard InChI: InChI=1S/C16H16N2O2/c1-10-6-3-4-7-11(10)15-17-12-8-5-9-13(20-2)14(12)16(19)18-15/h3-9,15,17H,1-2H3,(H,18,19)
Standard InChI Key: YHCIOAQQYLFMFI-UHFFFAOYSA-N
Molfile:
RDKit 2D
20 22 0 0 0 0 0 0 0 0999 V2000
-2.5001 -0.4165 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7833 -0.8249 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0727 -0.4128 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3577 -0.8257 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.3573 -0.4129 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3573 0.4127 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.3577 0.8256 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0727 0.4127 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7851 0.8249 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5001 0.4123 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3577 1.6513 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.0724 -0.8257 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0724 -1.6549 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7894 -2.0634 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5001 -1.6512 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5001 -0.8253 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7876 -0.4130 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7851 1.6506 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.5001 2.0634 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7876 0.4125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 1 0
6 7 1 0
8 7 1 0
3 8 2 0
8 9 1 0
9 10 2 0
10 1 1 0
7 11 2 0
5 12 1 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 12 2 0
9 18 1 0
18 19 1 0
17 20 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 268.32 | Molecular Weight (Monoisotopic): 268.1212 | AlogP: 2.86 | #Rotatable Bonds: 2 |
Polar Surface Area: 50.36 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 11.00 | CX Basic pKa: ┄ | CX LogP: 3.40 | CX LogD: 3.40 |
Aromatic Rings: 2 | Heavy Atoms: 20 | QED Weighted: 0.88 | Np Likeness Score: -0.34 |
References
1. Shishodia S, Nuñez R, Strohmier BP, Bursch KL, Goetz CJ, Olp MD, Jensen DR, Fenske TG, Ordonez-Rubiano SC, Blau ME, Roach MK, Peterson FC, Volkman BF, Dykhuizen EC, Smith BC.. (2022) Selective and Cell-Active PBRM1 Bromodomain Inhibitors Discovered through NMR Fragment Screening., 65 (20.0): [PMID:36227159] [10.1021/acs.jmedchem.2c00864] |